457 related articles for article (PubMed ID: 6752444)
1. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
[TBL] [Abstract][Full Text] [Related]
2. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
4. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
Kickler TS; Ness PM; Braine HG
Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
[TBL] [Abstract][Full Text] [Related]
5. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
Yam P; Petz LD; Scott EP; Santos S
Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
[TBL] [Abstract][Full Text] [Related]
6. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
7. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
[TBL] [Abstract][Full Text] [Related]
9. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
[TBL] [Abstract][Full Text] [Related]
10. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
11. Determination of an appropriate size of unrelated donor pool to be registered for HLA-matched platelet transfusion.
Takahashi K; Juji T; Miyazaki H
Transfusion; 1987; 27(5):394-8. PubMed ID: 3477043
[TBL] [Abstract][Full Text] [Related]
12. Four crossmatch methods to select platelet donors.
Kakaiya RM; Gudino MD; Miller WV; Sherman LA; Katz AJ; Wakem CJ; Krugman DJ; Klatsky AU; Kiraly TR
Transfusion; 1984; 24(1):35-41. PubMed ID: 6364475
[TBL] [Abstract][Full Text] [Related]
13. Platelet crossmatching with Capture P: clinical relevance.
Böck M; Heim MU; Schleich I; Weindler R; Wagner M; Mempel W
Infusionstherapie; 1989 Aug; 16(4):183-5. PubMed ID: 2807565
[No Abstract] [Full Text] [Related]
14. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
O'Connell BA; Lee EJ; Rothko K; Hussein MA; Schiffer CA
Blood; 1992 Jan; 79(2):527-31. PubMed ID: 1730095
[TBL] [Abstract][Full Text] [Related]
15. Use of in vitro assays in selection of compatible platelet donors.
Tosato G; Appelbaum FR; Trapani RJ; Dowling R; Deisseroth AB
Transfusion; 1980; 20(1):47-54. PubMed ID: 7355471
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
Freedman J; Gafni A; Garvey MB; Blanchette V
Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
[TBL] [Abstract][Full Text] [Related]
17. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients.
Chow MP; Yung CH; Hu HY; Tzeng JL; Lin WM; Lin CK
Transfusion; 1991 Sep; 31(7):595-9. PubMed ID: 1891789
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
Brubaker DB; Duke JC; Romine M
Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
[TBL] [Abstract][Full Text] [Related]
20. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
